TMC Life Sciences Berhad Income Statement

Financials in millions MYR. Fiscal year is July - June.

Millions MYR. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	387.12	345.54	346.42	311.44	243.77	201.02
Other Revenue	0.1	0.1	-	0.11	-	-
Revenue	387.22	345.63	346.42	311.56	243.77	201.02
Revenue Growth (YoY)	20.03%	-0.23%	11.19%	27.81%	21.27%	9.20%
Cost of Revenue	257.64	235.97	208.4	185.5	155.89	131.52
Gross Profit	129.57	109.67	138.02	126.06	87.88	69.5
Other Operating Expenses	68.01	63.36	52.75	53	39.94	30.65
Operating Expenses	105.01	97.46	80.66	79.01	55.79	43.67
Operating Income	24.56	12.21	57.36	47.05	32.09	25.84
Interest Expense	-8.51	-9.32	-10.25	-9.4	-2.09	-0.44
Interest & Investment Income	2.94	4.17	5.47	3.25	2	2.19
EBT Excluding Unusual Items	19	7.06	52.58	40.89	32	27.58
Gain (Loss) on Sale of Assets	0.01	0.01	-	-	-	0.06
Other Unusual Items	0	0	0.04	-	0.18	0.03
Pretax Income	19.01	7.07	52.62	40.89	32.18	27.67
Income Tax Expense	6.42	3.47	11.97	1.63	-9.21	7.42
Net Income	12.59	3.61	40.65	39.26	41.39	20.25
Net Income to Common	12.59	3.61	40.65	39.26	41.39	20.25
Net Income Growth	-2.95%	-91.13%	3.54%	-5.15%	104.35%	27.14%
Shares Outstanding (Basic)	1,742	1,742	1,742	1,742	1,742	1,742
Shares Outstanding (Diluted)	1,742	1,742	1,742	1,742	1,742	1,742
EPS (Basic)	0.01	0.00	0.02	0.02	0.02	0.01
EPS (Diluted)	0.01	0.00	0.02	0.02	0.02	0.01
EPS Growth	-2.95%	-91.13%	3.71%	-5.31%	104.85%	27.18%
Free Cash Flow	13.38	-18.2	49.41	22.61	-32.04	-80.18
Free Cash Flow Per Share	0.01	-0.01	0.03	0.01	-0.02	-0.05
Dividend Per Share	-	0.002	0.005	0.004	0.003	0.002
Dividend Growth	-	-61.96%	16.65%	51.97%	24.74%	9.98%
Gross Margin	33.46%	31.73%	39.84%	40.46%	36.05%	34.57%
Operating Margin	6.34%	3.53%	16.56%	15.10%	13.16%	12.85%
Profit Margin	3.25%	1.04%	11.73%	12.60%	16.98%	10.08%
Free Cash Flow Margin	3.46%	-5.27%	14.26%	7.26%	-13.15%	-39.89%
EBITDA	52.08	37.81	80.28	68.43	44.62	36.02
EBITDA Margin	13.45%	10.94%	23.17%	21.96%	18.30%	17.92%
D&A For EBITDA	27.51	25.6	22.92	21.38	12.54	10.19
EBIT	24.56	12.21	57.36	47.05	32.09	25.84
EBIT Margin	6.34%	3.53%	16.56%	15.10%	13.16%	12.85%
Effective Tax Rate	33.77%	49.01%	22.75%	3.99%	-	26.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.